Skip to content

The effect of Hyaluronic Acid in repair of ear drum

The effect of Hyaluronic Acid on graft success rate in tympanoplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014020915496N9
Enrollment
400
Registered
2015-09-17
Start date
2015-01-25
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tympanoplasty. Perforation of tympanic membrane

Interventions

Intervention 1: In intervention group Hyaluronic Acid applied inside and outside of middle ear. Intervention 2: In control group Gelfoam applied inside and outside of middle ear.
Treatment - Surgery
In intervention group Hyaluronic Acid applied inside and outside of middle ear.
In control group Gelfoam applied inside and outside of middle ear.

Sponsors

Vice Chancellor of Research, Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients more than 18 years old; tympanic perforation =50 %. Exclusion criteria: Patients suffered from underlying diseases such as: asthma, diabetes, coagulation disorders, cardiovascular disease, basic metabolic disorder, immune system deficiency and chronic liver or renal disease; Smokers; Revision tympanoplasty; Patients with contra-lateral ear disease; Presence of cholesteatoma; Presence of tympanosclelerotic plaque in middle ear; Presence of granulation tissue in middle ear.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Tympanic membrane graft success rate. Timepoint: within 6 months after surgery. Method of measurement: Observation by physician.;Hearing threshold. Timepoint: before operation, 6 months after operation. Method of measurement: pure tone audiometry.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSareh Roosta

Center for Development of Clinical Studies, Vice Chancellor of Research and Technology, Shiraz Unive

Roosta.Sareh@gmail.com+98 71 3612 5323

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026